Search clinical trials for: Placebo Subcutaneous Solution

Total 69116 results

EyePoint Pharmaceuticals, Inc.
Medical Technology Enterprise Consortium (MTEC)

Terminated

Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019 (RESCUE)

COVID-19 | Acute Respiratory Distress Syndrome (ARDS)

United States
Lundquist Institute for Biomedical Innovation at...

Completed

Semaglutide Treatment On Coronary Progression (STOP)

Coronary Artery Disease | Type 2 Diabetes

United States
Geisinger Clinic

Terminated

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy (RAISE-KT)

Obesity | Diabetic Kidney Disease | Type 2 Diabetes Mellitus in Obese | CKD | Severe Obesity

United States
Zuyderland Medisch Centrum
Nederlandse Obestias Kliniek (NOK)

Not yet recruiting

Semaglutide 2.4mg for Low Responders After Bariatric Surgery (SEABAR)

Obesity | Obesity, Morbid | Weight Gain
Arbeitsgemeinschaft medikamentoese Tumortherapie
Amgen; Assign Data Management and Biostatistics GmbH

Active, not recruiting

Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients (DEFENCE)

Multiple Myeloma

Austria, Germany, Israel
Stealth BioTherapeutics Inc.

Completed

ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA (ReCLAIM-2)

Age-related Macular Degeneration

United States
Maimónides Biomedical Research Institute of Córdoba
Consejería de Salud y Familias - Junta de Andalucía; Red Andaluza de Ensayos...

Completed

Clinical Trial of Sarilumab in Adults With COVID-19 (SARICOR)

SARS-CoV 2 | SARS

Spain
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use

Migraine Disorders

Japan
Novartis Pharmaceuticals

Completed

Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)

Treatment-Resistant Depression

Spain, Japan, Poland, United States
AstraZeneca
Parexel

Completed

A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of Sub-Saharan West African Ancestry

Healthy Volunteers

United States
AstraZeneca
Parexel

Completed

A First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD2373 After Single Dose Administration in Healthy Male Subjects of African Ancestry.

Healthy Volunteers

United States
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects

Healthy Subjects | Pharmacokinetics of ASP6294

United Kingdom
Baxter Healthcare Corporation
Halozyme Therapeutics

Terminated

Study of In-line Pressure Using Various Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase (INFUSE-AT1A) (INFUSE-AT1A)

Dehydration

United States
Eli Lilly and Company

Completed

A Study of LY3016859 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Geropharm

Completed

Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients

Diabetes Mellitus | Diabetes Mellitus, Type 1

Russian Federation
AgoneX Biopharmaceuticals, Inc.

Not yet recruiting

A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous AGX-201 for Migraine Prophylaxis

Migraine Prophylaxis
University of Alexandria

Completed

Efficacy of Neural Prolotherapy in Treatment of Meralgia Paresthetica

Meralgia Paresthetica

Egypt
Instituto de Investigación Marqués de Valdecilla

Unknown

Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET) (SARIPET)

Rheumatoid Arthritis | Atherosclerosis
University of South Florida

Recruiting

Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

United States
Regado Biosciences, Inc.

Completed

Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD (SC101)

Healthy Volunteer

United States
Baxter Healthcare Corporation
Halozyme Therapeutics

Completed

Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase (INFUSE-AT)

Dehydration

United States
Pfizer

Terminated

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

Healthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune Thrombocytopenia

Spain, United States, Belgium, United Kingdom, New Zealand
AstraZeneca
Parexel

Completed

To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia

Dyslipidemia

United States
Emory University
Sanofi

Recruiting

Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT) (ADAPT)

Allergic Fungal Rhinosinusitis

United States
AstraZeneca

Completed

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

Chronic Pain

Germany, Sweden, United Kingdom
UCB Biopharma SRL

Active, not recruiting

A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

Atopic Dermatitis

Bulgaria, Germany, Netherlands, United Kingdom
Hoffmann-La Roche

Terminated

A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (LISAH)

Breast Cancer

Austria
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

A Study of STSA-1201 in Healthy Subjects

Healthy

China
Emma Guttman

Completed

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Leptin in Human Energy and Neuroendocrine Homeostasis

Obesity | Weight Loss

United States
Baylor Research Institute

Withdrawn

Benralizumab in the Treatment of Patients With Severe Asthma With ABPA

Severe Asthma | Allergic Bronchopulmonary Aspergillosis | ABPA

United States
Inmunotek S.L.

Unknown

Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy (MM09)

Rhinitis | Rhinoconjunctivitis

Spain
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

China
Oneness Biotech Co., Ltd.

Active, not recruiting

A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adults

Atopic Dermatitis

United States
GlaxoSmithKline

Completed

Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study

Arthritis, Rheumatoid

Russian Federation
UCB Celltech
Parexel

Completed

A First-In-Human Study With a Single Dose UCB7665 in Healthy Volunteers

Healthy

United Kingdom
Inmunotek S.L.
BioClever 2005 S.L.

Recruiting

Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites (MM09-SIT-023)

Rhinitis, Allergic | Rhinoconjunctivitis | Asthma, Allergic

Spain
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects

Primary Immune Thrombocytopenia

China
Inmunotek S.L.

Completed

Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy (MG56)

Rhinitis | Rhinoconjunctivitis

Spain
Anergis

Terminated

Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen (AN003)

Allergy | Allergic Rhinitis

Switzerland
Inmunotek S.L.
BioClever 2005 S.L.; NTS hub S.L

Not yet recruiting

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Perennial Allergic Rhinitis | Allergic Asthma | Allergic Rhinoconjunctivitis | House Dust Mite Allergy

Spain
AstraZeneca

Completed

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

Healthy Elderly | Mild-Moderate Alzheimer's Disease

United States
University of North Carolina, Chapel Hill
AbbVie

Completed

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Psoriasis

United States
Pfizer

Active, not recruiting

A Preliminary Study to Evaluate PF-07264660 in Healthy Participants

Healthy

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery (DRIFTER)

Type 2 Diabetes | Bariatric Surgery

France
Immunovant Sciences GmbH

Terminated

ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

Graves' Ophthalmopathy (GO)

United States, Germany, Spain, Canada, Italy
Lawson Health Research Institute
Mount Sinai Hospital, Canada

Recruiting

Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis

Chronic Rhinosinusitis With Nasal Polyps | Olfactory Disorder

Canada
Rochester General Hospital
Takeda

Recruiting

Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention

COPD Exacerbation Acute

United States
Minneapolis Heart Institute Foundation
Regeneron Pharmaceuticals

Terminated

The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial (ASAP-SVG)

Saphenous Vein Graft Atherosclerosis

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate Safety and Tolerability of JNJ-61178104 in Healthy Participants

Healthy

Belgium

Search clinical trials for: Placebo Subcutaneous Solution

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations